Prospective study of congenital toxoplasmosis screening with use of IgG avidity and multiplex nested PCR methods

Journal of Clinical Microbiology

Volumn 49, Issue 7, 2011, Pages 2552-2556

  Yamada, Hideto ^a   Nishikawa, Akira ^b   Yamamoto, Tomohiro ^c   Mizue, Yuka ^d   Yamada, Takashi ^e   Morizane, Mayumi ^a   Tairaku, Shinya ^a   Nishihira, Jun ^f  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b Sapporo Medical Center   (Japan)

^c GeneticLab Co   (Japan)

^d Sapporo Immuno Diagnostic Laboratory   (Japan)

^e HOKKAIDO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^f HOKKAIDO INFORMATION UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

PROTOZOON ANTIBODY;

AMNIOCENTESIS; AMNION FLUID; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ARTICLE; CONGENITAL TOXOPLASMOSIS; CONTROLLED STUDY; FEMALE; HIGH RISK PREGNANCY; HUMAN; IGG AVIDITY; MAJOR CLINICAL STUDY; MATERNAL BLOOD; MULTIPLEX POLYMERASE CHAIN REACTION; NUCLEOTIDE SEQUENCE; PREGNANT WOMAN; PRIORITY JOURNAL; PROSPECTIVE STUDY; RAW MEAT; RISK FACTOR; SCREENING TEST; TOXOPLASMA GONDII; UMBILICAL CORD BLOOD;

AMNIOTIC FLUID; ANTIBODIES, PROTOZOAN; ANTIBODY AFFINITY; CHILD, PRESCHOOL; FEMALE; HUMANS; IMMUNOASSAY; IMMUNOGLOBULIN G; INFANT; INFANT, NEWBORN; MALE; MASS SCREENING; POLYMERASE CHAIN REACTION; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PROGNOSIS; PROSPECTIVE STUDIES; TOXOPLASMA; TOXOPLASMOSIS;

TOXOPLASMA GONDII;

EID: 79959841097     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.02092-10     Document Type: Article

References (21)

1. Bobić, B., D. Sibalić, and O. Djurković- Djaković. 1991. High levels of IgM antibodies specific for Toxoplasma gondii in pregnancy 12 years after primary toxoplasma infection. Case report. Gynecol. Obstet. Invest. 31:182-184.
2. Calderaro, A., et al. 2006. Comparison between two real-time PCR assays and a nested-PCR for the detection of Toxoplasma gondii. Acta Biomed. 77:75-80.
3. Candolfi, E., R. Pastor, R. Huber, D. Filisetti, and O. Villard. 2007. IgG avidity assay firms up the diagnosis of acute toxoplasmosis on the first serum sample in immunocompetent pregnant women. Diagn. Microbiol. Infect. Dis. 58:83-88.
4. Candolfi, E., R. Ramirez, M. P. Hadju, C. Shubert, and J. S. Remington. 1994. The Vitek immunodiagnostic assay for detection of immunoglobulin M toxoplasma antibodies. Clin. Diagn. Lab. Immunol. 1:401-405.
5. Cook, A. J., et al. 2000. Sources of toxoplasma infection in pregnant women: European multicentre case-control study. BMJ 321:142-147. (Pubitemid 30447005)
6. Del Bono, V., A. Canessa, P. Bruzzi, M. A. Fiorelli, and A. Terragna. 1989. Significance of specific immunoglobulin M in the chronological diagnosis of 38 cases of toxoplasmic lymphadenopathy. J. Clin. Microbiol. 27:2133-2135.
7. Fricker-Hidalgo, H., et al. 1997. Prenatal diagnosis of congenital toxoplasmosis: comparative value of fetal blood and amniotic fluid using serological techniques and cultures. Prenat. Diagn. 17:831-835.
8. Guerina, N. G. 1994. Congenital infection with Toxoplasma gondii. Pediatr. Ann. 23:138-151.
9. Hedman, K., M. Lappalainen, I. Seppäiä, and O. Mäkelä. 1989. Recent primary toxoplasma infection indicated by a low avidity of specific IgG. J. Infect. Dis. 159:736-740.
10. Hohlfeld, P., et al. 1994. Prenatal diagnosis of congenital toxoplasmosis with a polymerase-chain-reaction test on amniotic fluid. N. Engl. J. Med. 331:695-699.
11. Jones, J. L., et al. 2009. Risk factors for Toxoplasma gondii infection in the United States. Clin. Infect. Dis. 49:878-884.
12. Jones, J. L., et al. 2001. Toxoplasma gondii infection in the United States: seroprevalence and risk factors. Am. J. Epidemiol. 154:357-365.
13. Khin-Sane-Win, T. Matsumura, S. Kumagai, S. Uga, and E. Konishi. 1997. Prevalence of antibody to Toxoplasma gondii in Hyogo Prefecture, Japan: comparison at a 10-year interval. Kobe J. Med. Sci. 43:159-168.
14. Liesenfeld, O., et al. 1997. False-positive results in immunoglobulin M (IgM) toxoplasma antibody tests and importance of confirmatory testing: the Platelia Toxo IgM test. J. Clin. Microbiol. 35:174-178.
15. Nishikawa, A., M. Ryosaka, Y. Kitajima, M. Sugawara, and H. Yamada. 2006. Seroprevalence rates of Toxoplasma gondii in pregnant women of Hokkaido. J. Hokkaido Obstet. Gynecol. Soc. 51:20-22. (In Japanese.)
16. Nishikawa, A., et al. 2009. A case of congenital toxoplasmosis whose mother demonstrated serum low IgG avidity and positive tests for multiplex-nested PCR in the amniotic fluid. J. Obstet. Gynaecol. Res. 35:372-378.
17. Pratlong, F., et al. 1994. Fetal diagnosis of toxoplasmosis in 190 women infected during pregnancy. Prenat. Diagn. 14:191-198.
18. Romand, S., et al. 2004. Usefulness of quantitative polymerase chain reaction in amniotic fluid as early prognostic marker of fetal infection with Toxoplasma gondii. Am. J. Obstet. Gynecol. 190:797-802. (Pubitemid 38406796)
19. Tenter, A. M., A. R. Heckeroth, and L. M. Weiss. 2000. Toxoplasma gondii: from animals to humans. Int. J. Parasitol. 30:1217-1258.
20. Thalib, L., et al. 2005. Prediction of congenital toxoplasmosis by polymerase chain reaction analysis of amniotic fluid. BJOG 112:567-574. (Pubitemid 40675790)
21. Wong, S. Y., and J. S. Remington. 1994. Toxoplasmosis in pregnancy. Clin. Infect. Dis. 18:853-861.